sponsored
PatientsVille.com Logo

PatientsVille

Cephalexin and Norco

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectCephalexinNorco
DEATH0.9% 10.4%
TOXICITY TO VARIOUS AGENTS0% 8.3%
OVERDOSE0% 3.9%
PAIN3.3% 2.8%
NAUSEA2.8% 2.8%
FATIGUE2.5% 2.7%
DRUG INEFFECTIVE1.4% 2.7%
DIARRHOEA2.4% 2%
DYSPNOEA2.3% 1.7%
ANXIETY2.3% 1.3%
HEADACHE1.8% 1.9%
DIZZINESS1.9% 1.5%
CHRONIC KIDNEY DISEASE1.9% 0.5%
VOMITING1.8% 1.5%
RENAL FAILURE1.8% 0.5%
FALL1.7% 1.6%
DEPRESSION1.7% 1.2%
RASH1.7% 0.9%
INJURY1.7% 0.5%
ASTHENIA1.6% 1.4%
PAIN IN EXTREMITY1.5% 1.3%
ARTHRALGIA1.5% 1.3%
URINARY TRACT INFECTION1.5% 0.7%
DRUG HYPERSENSITIVITY1.5% 0.6%
MALAISE1.1% 1.4%
HYPERTENSION1.4% 0.7%
PYREXIA1.4% 0.7%
ACUTE KIDNEY INJURY1.4% 0.6%
DRUG ABUSE0% 1.4%
BACK PAIN1.3% 1.2%
CHEST PAIN1.3% 0.8%
DEEP VEIN THROMBOSIS1.3% 0.6%
PNEUMONIA1.2% 1.2%
ABDOMINAL PAIN1.2% 0.9%
PRURITUS1.2% 0.7%
COMPLETED SUICIDE0% 1.2%
WEIGHT DECREASED1.1% 1.1%
INSOMNIA1% 1.1%
ANAEMIA1.1% 0.7%
OEDEMA PERIPHERAL1.1% 0.5%
CONSTIPATION1% 1%
COUGH1% 0.7%
PULMONARY EMBOLISM1% 0.6%
MYOCARDIAL INFARCTION1% 0.4%
EMOTIONAL DISTRESS1% 0.4%
ABDOMINAL PAIN UPPER0.9% 0.7%
HYPOAESTHESIA0.9% 0.7%
DEHYDRATION0.9% 0.6%
HYPOTENSION0.9% 0.5%
CEREBROVASCULAR ACCIDENT0.9% 0.4%
DRUG DEPENDENCE0% 0.9%
CELLULITIS0.9% 0%
OFF LABEL USE0% 0.9%
DECREASED APPETITE0.8% 0.8%
MUSCLE SPASMS0.8% 0.8%
GAIT DISTURBANCE0.7% 0.8%
FEELING ABNORMAL0.6% 0.8%
CONFUSIONAL STATE0.8% 0.6%
DRUG DOSE OMISSION0.5% 0.8%
CARDIAC FAILURE CONGESTIVE0.8% 0.4%
GASTROOESOPHAGEAL REFLUX DISEASE0.8% 0.4%
ECONOMIC PROBLEM0.8% 0%
WEIGHT INCREASED0.6% 0.7%
CONDITION AGGRAVATED0.6% 0.7%
SOMNOLENCE0.6% 0.7%
PARAESTHESIA0.7% 0.5%
SINUSITIS0.7% 0.4%
BRONCHITIS0.7% 0.4%
ERYTHEMA0.7% 0.3%
URTICARIA0.7% 0%
TREMOR0.6% 0.6%
MYALGIA0.6% 0.5%
PERIPHERAL SWELLING0.5% 0.6%
ABDOMINAL DISCOMFORT0.5% 0.6%
CONTUSION0.6% 0.4%
ATRIAL FIBRILLATION0.6% 0.4%
NEUROPATHY PERIPHERAL0.6% 0.4%
MEMORY IMPAIRMENT0% 0.6%
CORONARY ARTERY DISEASE0.6% 0%
DIABETES MELLITUS0.6% 0%
INFECTION0.6% 0%
OSTEOARTHRITIS0.6% 0%
PALPITATIONS0.6% 0%
CHOLELITHIASIS0.6% 0%
ACCIDENTAL OVERDOSE0% 0.6%
ANHEDONIA0.6% 0%
DYSPHAGIA0.6% 0%
MUSCULAR WEAKNESS0.5% 0.5%
HYPERHIDROSIS0.5% 0.5%
ALOPECIA0.5% 0.5%
VISION BLURRED0.5% 0.4%
LOSS OF CONSCIOUSNESS0.5% 0.4%
HYPERSENSITIVITY0.5% 0.4%
DYSPEPSIA0.5% 0.4%
HAEMOGLOBIN DECREASED0.5% 0.4%
SEPSIS0.5% 0.4%
CHILLS0.5% 0.3%
INTENTIONAL PRODUCT MISUSE0% 0.5%
CARDIO-RESPIRATORY ARREST0% 0.5%
GASTROINTESTINAL HAEMORRHAGE0% 0.5%
BLOOD PRESSURE INCREASED0% 0.5%
CHOLECYSTITIS CHRONIC0.5% 0%
GENERAL PHYSICAL HEALTH DETERIORATION0.5% 0%
OSTEOPOROSIS0.5% 0%
CHEST DISCOMFORT0.5% 0%
SYNCOPE0.5% 0%
ARTHRITIS0.5% 0%
SWELLING0.5% 0%
END STAGE RENAL DISEASE0.5% 0%
RENAL FAILURE ACUTE0.5% 0%
DRUG INTERACTION0.5% 0%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0.5% 0%
CARDIAC ARREST0% 0.4%
JOINT SWELLING0% 0.4%
DRUG EFFECT DECREASED0% 0.4%
NASOPHARYNGITIS0% 0.4%
INJECTION SITE PAIN0% 0.4%
MIGRAINE0% 0.4%
BALANCE DISORDER0% 0.4%
ABDOMINAL DISTENSION0% 0.3%
PRODUCT QUALITY ISSUE0% 0.3%
INFLUENZA0% 0.3%

New treatments are found every day. View current Cephalexin research studies and Norco clinical trials

1